Appian appoints Carl 'Boe' Hartman II to board, effective Oct 1, 2024

APPIAN CORP

Hartman is Co-Founder and CTO of Nomi Health; previously Partner at Goldman Sachs.
Appointed to Compensation Committee; independent director per Nasdaq and SEC rules.
Annual retainer of $250,000, paid half cash and half fully-vested Class A shares.
Term runs until the 2025 annual meeting of stockholders.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Carl “Boe” Hartman II

director

APPN · APPIAN CORP

Effective: 2024-10-01
Filed: October 1, 2024, 7:59 PM ET

On September 25, 2024, the Board of Directors appointed Carl “Boe” Hartman II to the Board, effective as of October 1, 2024, to serve until our annual meeting of stockholders to be held in 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Carl “Boe” Hartman II was appointed as director at APPIAN CORP.

Action: appointed
Role: director

Exact text from the filing

On September 25, 2024, the Board of Directors appointed Carl “Boe” Hartman II to the Board, effective as of October 1, 2024, to serve until our annual meeting of stockholders to be held in 2025.

View on SEC.gov

APPIAN CORP filing history →

Source: SEC EDGAR

accession 0001441683-24-000083

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.